Welcome to our dedicated page for COGNEX SEC filings (Ticker: CGNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cognex Corporation filings document regulatory disclosures for an operating company focused on industrial machine vision products and automation technology. Its Form 8-K reports cover furnished operating results, quarterly cash dividends, share repurchase authorization, board and officer matters, annual meeting voting results, and changes in the company’s independent registered public accounting firm.
Proxy materials describe director elections, governance matters, executive compensation, shareholder voting procedures, and board committee oversight. The filing record also includes exhibit-based disclosures tied to financial-results releases and capital-return actions involving Cognex common stock.
COGNEX CORP director Dianne M. Parrotte reported equity award activity involving restricted stock units and common shares. On February 18, 2026, she exercised or converted 8,324 restricted stock units into 8,324 shares of Cognex common stock at a stated price of $0.00 per share, increasing her direct common stock holdings to 30,518 shares.
The filing also lists updated direct holdings of several non-qualified stock options with rights to buy 7,500, 18,400 and 18,100 shares, and 2,913 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Cognex common stock and vests 100% on the first anniversary of the grant date, stated as February 18, 2025.
COGNEX CORP CEO & President Matthew Moschner reported equity awards and vesting activity. On February 18, 2026, 5,085 restricted stock units converted into common stock, with 1,600 shares withheld at $56.7200 per share to satisfy tax withholding obligations.
On February 17, 2026, he received 58,744 non-qualified stock options at an exercise price of $57.0900 and 56,928 restricted stock units, which vest over future anniversaries of the grant date. Following these events he directly holds 93,874 restricted stock units, 11,847 common shares, and options for 697,280 shares.
Cognex Corporation senior vice president and chief financial officer Dennis Fehr reported several equity compensation movements. On February 17, 2026, he was granted 25,306 non-qualified stock options and 24,523 restricted stock units, both at a price of $0.00 per unit. The options vest in five approximately equal annual installments beginning one year after the grant date, while the restricted stock units vest 20%, 30%, and 50% over three years.
On February 18, 2026, 5,085 restricted stock units were converted into the same number of common shares, and 1,618 common shares were disposed of to satisfy tax withholding obligations at $56.72 per share. Following these transactions, Fehr directly owned 14,196 common shares and held 20,339 restricted stock units, along with substantial option holdings.
COGNEX CORP director Angelos Papadimitriou reported equity awards and conversions. On February 18, 2026, he exercised 8,324 restricted stock units at $0.0000 per share into the same number of common shares, bringing his direct common stock holdings to 17,835 shares. On February 17, 2026, he received a grant of 4,817 restricted stock units, which each represent a contingent right to one Cognex common share and vest 100% on the first anniversary of the grant date.
Cognex Corporation’s Chief Technology Officer, Joerg Kuechen, reported several equity-related transactions. On February 18, 2026, 4,056 restricted stock units were converted into an equal number of common shares at $0.00 per share, and 1,327 of those shares were disposed of at $56.72 per share to cover tax withholding obligations rather than through an open‑market sale. After these transactions, he directly held 2,729 shares of common stock. On February 17, 2026, he also received a direct grant of 8,759 new restricted stock units, which vest 100% on the second anniversary of the grant date. Additional non‑qualified stock options and restricted stock units are listed as existing holdings, reflecting his broader long‑term incentive position.
COGNEX CORP director John Tseng-Chung Lee reported equity compensation activity involving restricted stock units and common shares. On February 18, 2026, he exercised 8,324 restricted stock units for 8,324 shares of common stock at a price of $0.00 per share, bringing his direct common stock holdings to 21,907 shares.
On February 17, 2026, he received a grant of 4,817 restricted stock units, and a separate line shows 2,913 restricted stock units held directly after another transaction. Each restricted stock unit represents the right to receive one share of Cognex common stock, with footnotes indicating these awards vest 100% on the first anniversary of their respective grant dates.
COGNEX CORP director Marjorie Sennett reported equity award activity involving restricted stock units and common shares. On February 18, 2026, restricted stock units covering 8,324 shares were exercised for common stock at $0.0000 per share, leaving 23,023 common shares held directly.
On February 17, 2026, she received a grant of 4,817 restricted stock units, each representing a contingent right to one share of common stock. Footnotes state that certain restricted stock unit awards vest 100% on the first anniversary of their respective grant dates.
COGNEX CORP director Sachin Lawande reported equity awards and an RSU conversion. On February 18, 2026, 8,324 restricted stock units were exercised or converted into 8,324 shares of common stock at a stated price of $0.00 per share, leaving 25,518 common shares held directly.
On February 17, 2026, Lawande received a grant of 4,817 restricted stock units, each representing a contingent right to one share of Cognex common stock. Footnotes state that one RSU grant vests 100% on the first anniversary of the February 18, 2025 grant date, and another vests 100% on the first anniversary of the February 17, 2026 grant date.
COGNEX CORP executive Carl Gerst reported multiple equity award transactions. On February 17, 2026, he received a grant of 24,854 non-qualified stock options and 24,085 restricted stock units (RSUs), each at a price of $0.00 per share.
The options vest in five approximately equal annual installments on the first through fifth anniversaries of the February 17, 2026 grant date. The RSUs granted on that date vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries, respectively. Each RSU represents a contingent right to receive one share of Cognex common stock.
On February 18, 2026, 5,570 RSUs vested and were converted into 5,570 shares of common stock. Of these, 1,766 shares were withheld at $56.72 per share to satisfy tax withholding obligations, leaving 3,804 common shares directly held afterward.
Cognex Corp VP and principal accounting officer Laura Ann Macdonald reported multiple equity transactions. On February 17, 2026, she received a grant of 7,231 non-qualified stock options and 11,211 restricted stock units (RSUs), each RSU representing the contingent right to one common share. The options vest in five approximately equal annual installments beginning on the first anniversary of the grant date, while the RSUs vest 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date.
On February 18, 2026, 2,422 RSUs vested and were converted into the same number of common shares. Of these, 711 shares, valued at $56.72 per share, were withheld to satisfy tax withholding obligations, leaving her with 3,923 directly held common shares and 9,685 RSUs. An additional 20 common shares are held indirectly by her child, for which she disclaims beneficial ownership except to the extent of her pecuniary interest.